Stocks to buy in 2025 for long term: Sun Tv, Glenmark Pharma among 5 stocks that could give 17-33% return – Brokerage Recommendations
Elara Capital on Sun TV Networks: Buy| Target Rs 730| LTP Rs 571| Upside 27%Elara Capital also has a Buy ...
Tag: Pharma
ET Market Watch: Nifty, Sensex rebound sharply on NDA’s Bihar victory, PSU banks, pharma shine | The Economic Times Podcast
Hi, I’m Neha Vashishth and welcome to ET Market Watch, your daily podcast, where we break down the biggest market ...
Torrent Pharma Q2 Results: Net profit jumps 30% to Rs 591 crore
Torrent Pharmaceuticals on Friday reported a 30 per cent surge in its consolidated profit after tax at Rs 591 crore ...
Big US pharma stocks rise as Street reacts to Trump’s tariff on drugs
Shares of some big drugmakers advanced above broader indexes Friday as Wall Street started sorting out President Donald Trump's latest ...
South Korean shares hit fresh record as chip, pharma stocks rally
Round-up of South Korean financial markets: ** South Korean shares rose to a record high on Tuesday as chipmakers rallied ...
ET Market Watch: Nifty above 25,400, Sensex at 83,000; IT & pharma stocks surge after Fed rate cut | The Economic Times Podcast
Hi, you’re listening to ET Markets Radio, I’m your host Neha Vashishth. Welcome to a fresh episode of ET Market ...
Markets cheer as Trump-Modi trade talk optimism boosts sentiment
Positive signals are emerging from the ongoing trade discussions between the US and India, with both US President Donald Trump ...
Torrent Pharma seeks CCI nod to acquire majority stake in JB Chemicals for Rs 19,500 cr
New Delhi, Ahmedabad-based Torrent Pharmaceuticals has sought fair trade regulator CCI's clearance to acquire a majority stake in in J ...
Breakout Stocks: How to trade Glenmark Pharma, Jaiprakash Power Ventures and EID Parry that hit fresh 52-week high? – Market Summary
EID Parry is currently forming a Higher High, Higher Low structure, suggesting an ongoing uptrend. However, the stock has surged ...
Motilal Oswal sees 28% upside in Glenmark Pharma, hails $700 mln cancer drug deal as ‘new era’ for innovation play
Motilal Oswal has reiterated a “buy” rating on Glenmark Pharmaceuticals with a raised target price of Rs 2,430, implying a ...
